Skip to Main Content

Advertisement

Skip Nav Destination

OnlineFirst

Research Article July 16 2025
IRF4 promotes immune evasion and shapes the tumor microenvironment in Follicular Lymphoma
Blood Cancer Discov (2025)
Research Article July 11 2025
Microbiota shape metabolic and immune determinants of CAR-T therapy and correlate with outcomes in myeloma
Blood Cancer Discov (2025)
Research Article July 9 2025
An isoform-specific RUNX1C–BTG2 axis governs AML quiescence and chemoresistance.
Blood Cancer Discov (2025)
Research Brief July 9 2025
Real-World Experience with Teclistamab for Relapsed/ Refractory Multiple Myeloma from the U.S. Myeloma Immunotherapy Consortium
Blood Cancer Discov (2025)
Research Article July 3 2025
Multi-Modal and Data-Driven Assessment of Myeloid Neoplasms Refines Classification Across Disease States
Blood Cancer Discov (2025)
Research Article July 3 2025
Commensal bacteria drive B-cell lymphomagenesis in the setting of innate immunodeficiency
Blood Cancer Discov (2025)
Research Article June 27 2025
DLBCL cells emerge post CD19 CAR-T with cross-antigen resistance and a gene signature predictive of clinical CAR-T response
Blood Cancer Discov (2025)
Research Article May 28 2025
Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia
Blood Cancer Discov (2025)
Research Article May 22 2025
Mutagenic impact and evolutionary influence of chemo-radiotherapy in hematologic malignancies
Blood Cancer Discov (2025)
Research Article May 21 2025
Genetic and Phenotypic correlates of clinical outcomes with Venetoclax in Acute Myeloid Leukemia: The GEN-PHEN-VEN study
Blood Cancer Discov (2025)

or Create an Account

Close Modal
Close Modal